Diagnostics Laboratories Segment is Expected to be Fastest Growing During Forecast Period for SAM Region    

According to a new market research study on “SAM Acetaminophen Reagents Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product, Application, and End User” is expected to reach US$ 45.62 million by 2028 from US$ 36.78 million in 2021. The market is estimated to grow at a CAGR of 3.1% from 2021 to 2028. The report provides trends prevailing in the SAM acetaminophen reagents market along with the drivers and restraints pertaining to the market growth. High incidence of drugs overdose and presence of limited key players in market are the major factor driving the growth of the SAM acetaminophen reagents market. However, increased risk of ADHD and other complication in pregnancy hinder the growth of SAM acetaminophen reagents market.     

In case of COVID-19, SAM is highly affected especially Brazil. With the outbreak of second wave COVID-19, there has been an increasing number of cases in the South American countries. Considerable number of countries in South America have very underdeveloped healthcare infrastructure. For instance, Peru, has less than 1000 intensive care unit beds for its 32 million inhabitants. Furthermore, supply chain disruption caused due to congestion of ports and disturbances in other transport means had substantial impact on the distribution of associated devices in the region. All these factors considerably deterred the growth of SAM acetaminophen reagents market. As the focus on COVID-19 patients became critical, the non-urgent medical procedures took a back seat. Several clinics have postponed or dropped numerous elective surgeries, especially those that are considered non-urgent. The markets associated with acetaminophen reagents would be severely affected.

The SAM acetaminophen reagents market has been segmented based on product, application, end user, and country. Based on product, the market has been segmented into antibody/substrate reagent, enzyme reagent, acetaminophen antiserum, acetaminophen fluorescein tracer, and pretreatment solution. The antibody/substrate reagent segment dominated the market in 2020 and enzyme reagent segment is expected to be fastest growing during forecast period. Based on application, the market has been segmented as enzymatic assays and immunoassay. The enzymatic assays segment dominated the market in 2020 and immunoassay segment is expected to be fastest growing during forecast period.  Based on end user, the market has been segmented into hospitals, diagnostics laboratories, POC testing, forensic laboratories, and others. The hospitals segment dominated the market in 2020 and diagnostics laboratories segment is expected to be fastest growing during forecast period. Based on country, the market has been segmented into Brazil, Argentina, and rest of SAM. 

Abbott; American Screening Corporation, Inc.; Beckman Coulter, Inc.; Bio-Rad Laboratories, Inc.; Biorbyt Ltd.; Randox Laboratories, Ltd.; Siemens Healthineers AG; and Thermo Fisher Scientific Inc. are among the leading companies in the SAM acetaminophen reagents market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2021, Siemens Healthineers and Sysmex Corporation announced the renewal of the companies' long-standing global supply, distributorship, sales and service agreement for a broad portfolio of hemostasis products including a multi-year extension.                      

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com